Allegheny Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Buy
1,472
+22
+2% +$4.21K 0.03% 226
2026
Q1
$266K Buy
1,450
+8
+0.6% +$1.47K 0.04% 237
2025
Q4
$254K Sell
1,442
-977
-40% -$160K 0.04% 230
2025
Q3
$339K Hold
2,419
– – 0.06% 182
2025
Q2
$304K Hold
2,419
– – 0.07% 186
2025
Q1
$331K Sell
2,419
-7
-0.3% -$1K 0.08% 173
2024
Q4
$371K Sell
2,426
-1
-0% -$169 0.1% 157
2024
Q3
$470K Sell
2,427
-433
-15% -$90.6K 0.12% 149
2024
Q2
$663K Buy
+2,860
New +$622K 0.19% 106

Other funds holding BIIB

Allegheny Financial Group's BIIB Position: Q2 2026 in Review

Allegheny Financial Group increased its Biogen (BIIB) stake by 1.5% in Q2 2026, buying an estimated $4.21K and bringing the position to 1,472 shares worth $318K. The position accounts for 0.03% of the portfolio, ranked #226.

Allegheny Financial Group first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $663K in Q2 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Allegheny Financial Group held 1,472 shares of Biogen worth $318K as of Q2 2026.
  • Allegheny Financial Group bought 22 Biogen shares in Q2 2026, an estimated $4.21K.
  • Biogen made up 0.03% of Allegheny Financial Group's portfolio in Q2 2026, its #226 holding.
  • Allegheny Financial Group first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
  • Allegheny Financial Group's Biogen position peaked at $663K in Q2 2024.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.